Basic Information
BioParadox is innovating Platelet Cell Therapy (PCT) for the treatment of cardiovascular diseases. The company's first products, VitaKine® and RevaTen®, are proprietary formulations that have been proven to enhance cardiovascular function. They are exclusively produced by BioParadox.
BioParadox,Inc.
California,United States of America
less than 15 people
January 01, 2008
info@bioparadox.com
Enterprise Profile
Technology
Concept